Olsen, E., Soraas, C., Mancia, G., Heimark, S., Mehlum, M., Liestöl, K., et al. (2023). SHOULD MIDDLE-AGED AND OLDER HIGH-RISK HYPERTENSIVE PATIENTS WITH DIABETES BE TREATED TO TARGET BT <130/80 MMHG?. In ESH 2023 Annual Meeting (pp.E34-E35). Lippincott Williams & Wilkins [10.1097/01.hjh.0000939176.73505.59].

SHOULD MIDDLE-AGED AND OLDER HIGH-RISK HYPERTENSIVE PATIENTS WITH DIABETES BE TREATED TO TARGET BT <130/80 MMHG?

Mancia, G;
2023

abstract
Peripheral Vascular Disease
English
ESH 2023 Annual Meeting - June 23-26 2023
2023
ESH 2023 Annual Meeting
2023
41
S3
E34
E35
none
Olsen, E., Soraas, C., Mancia, G., Heimark, S., Mehlum, M., Liestöl, K., et al. (2023). SHOULD MIDDLE-AGED AND OLDER HIGH-RISK HYPERTENSIVE PATIENTS WITH DIABETES BE TREATED TO TARGET BT <130/80 MMHG?. In ESH 2023 Annual Meeting (pp.E34-E35). Lippincott Williams & Wilkins [10.1097/01.hjh.0000939176.73505.59].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/447860
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact